Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skinosive is a French dermo-cosmetics biotechnology company developing a proprietary bioadhesion platform for long-lasting skin and hair protection products. Its lead application is a new generation of bioadhesive UV filters designed to remain on the skin surface for prolonged periods, improve photoprotection, and reduce skin penetration and environmental impact versus conventional sunscreen filters. The company reports clinically proven persistence of up to 8 hours for its photoprotection approach and is building a portfolio of UVA and UVB filter candidates. Beyond sun care, Skinosive is also exploring additional applications in hair protection and long-lasting cosmetic or make-up molecules. The company was created by Truffle Capital and operates from Paris and Marseille, France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skinosive.